Paolo Verdecchia Selected Research

Paolo Verdecchia Research Topics

Disease

47	Hypertension (High Blood Pressure) 11/2022 - 08/2002
23	Atrial Fibrillation 10/2021 - 05/2012
22	Stroke (Strokes) 11/2022 - 09/2004
14	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 11/2003
11	Heart Failure 07/2021 - 01/2004
10	Myocardial Infarction 07/2021 - 11/2005
10	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 01/2004
9	Hemorrhage 04/2019 - 01/2015
8	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2004
7	COVID-19 05/2022 - 01/2020
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 09/2005
6	Chronic Renal Insufficiency 11/2022 - 04/2011
5	Inflammation (Inflammations) 01/2022 - 12/2015
5	Insulin Resistance 01/2022 - 01/2004
5	Infarction (Infarctions) 01/2021 - 01/2010
5	Thromboembolism 02/2019 - 04/2013
5	Diabetes Mellitus 05/2017 - 11/2009
5	Hypertrophy 05/2011 - 10/2002
5	Essential Hypertension 01/2007 - 03/2002
4	Embolism (Embolus) 04/2019 - 01/2013
3	Thrombosis (Thrombus) 01/2022 - 01/2020
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2021 - 06/2008
3	Ischemic Stroke 04/2019 - 01/2014
3	Proteinuria 02/2012 - 01/2009
3	Diabetic Nephropathies (Diabetic Nephropathy) 04/2011 - 08/2007
3	Obesity 04/2008 - 01/2004
2	Hyperuricemia 01/2022 - 01/2021
2	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
2	Atherosclerosis 01/2022 - 01/2008
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 01/2013
2	Pneumonia (Pneumonitis) 01/2020 - 01/2020
2	Pain (Aches) 11/2018 - 12/2010
2	Osteoarthritis 11/2018 - 12/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 11/2010
2	Hyperglycemia 12/2015 - 01/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2013 - 01/2010
2	Acute Coronary Syndrome 08/2012 - 03/2012
1	Hypertensive Crisis 02/2022
1	Albuminuria 01/2022
1	Gout 01/2022
1	Coronary Restenosis 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Pulmonary Arterial Hypertension 12/2021

Drug/Important Bio-Agent (IBA)

18	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2004
18	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2004
17	AnticoagulantsIBA 04/2019 - 01/2013
14	DiureticsIBA 11/2022 - 09/2003
14	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 10/2002
10	Pharmaceutical PreparationsIBA 12/2020 - 08/2002
9	Uric Acid (Urate)IBA 11/2022 - 01/2020
9	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2022 - 09/2004
9	Vitamin K FDA Link 11/2018 - 05/2012
9	Dabigatran FDA Link 11/2018 - 01/2013
9	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 01/2013
7	aliskiren FDA Link 01/2014 - 01/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2005
6	Ramipril (Altace)FDA LinkGeneric 11/2017 - 10/2009
5	Angiotensin IIIBA 01/2022 - 01/2008
5	apixabanIBA 02/2019 - 01/2014
5	Telmisartan (Micardis)FDA Link 11/2017 - 10/2009
4	CreatinineIBA 01/2022 - 04/2010
4	CholesterolIBA 01/2021 - 01/2004
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2014 - 10/2009
3	Ethanol (Ethyl Alcohol)IBA 11/2022 - 01/2020
3	LDL CholesterolIBA 11/2022 - 01/2020
3	VaccinesIBA 05/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2011
3	CatecholaminesIBA 09/2019 - 01/2015
3	edoxabanIBA 12/2017 - 01/2014
3	N(4)-oleylcytosine arabinosideIBA 03/2017 - 01/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 03/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2017
2	Celecoxib (Celebrex)FDA Link 11/2018 - 08/2010
2	Amlodipine (Norvasc)FDA LinkGeneric 11/2018 - 09/2005
2	RivaroxabanIBA 12/2017 - 06/2017
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2015 - 01/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2015 - 04/2008
2	Renin InhibitorsIBA 07/2012 - 01/2007
2	Metformin (Glucophage)FDA LinkGeneric 10/2011 - 06/2011
2	Valsartan (Vals)FDA Link 05/2010 - 04/2004
2	HDL CholesterolIBA 03/2009 - 02/2006
2	MercuryIBA 12/2006 - 08/2006
2	1,4-dihydropyridine (dihydropyridine)IBA 09/2005 - 09/2004
1	AlbuminsIBA 01/2022
1	Allopurinol (Remid)FDA LinkGeneric 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Endothelin Receptor AntagonistsIBA 12/2021
1	macitentanIBA 12/2021
1	aprocitentanIBA 12/2021

Therapy/Procedure

21	Therapeutics 10/2021 - 03/2002
2	Denervation 03/2022 - 11/2014
2	Percutaneous Coronary Intervention 01/2022 - 10/2021
2	Contraindications 10/2021 - 08/2007
1	Drug Therapy (Chemotherapy) 02/2022
1	Stents 01/2022